Lionco Pharm Grp Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.54%

Lionco Pharm Grp Co Ltd (603669) has an Asset Resilience Ratio of 1.54% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 603669 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥18.53 Million

≈ $2.71 Million USD Cash + Short-term Investments

Total Assets

CN¥1.20 Billion

≈ $175.78 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Lionco Pharm Grp Co Ltd's Asset Resilience Ratio has changed over time. See Lionco Pharm Grp Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Lionco Pharm Grp Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lionco Pharm Grp Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥18.53 Million	1.54%
Total Liquid Assets	CN¥18.53 Million	1.54%

Asset Resilience Insights

Limited Liquidity: Lionco Pharm Grp Co Ltd maintains only 1.54% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Lionco Pharm Grp Co Ltd Industry Peers by Asset Resilience Ratio

Compare Lionco Pharm Grp Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Lionco Pharm Grp Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Lionco Pharm Grp Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.49%	CN¥31.22 Million ≈ $4.57 Million	CN¥1.26 Billion ≈ $183.69 Million	-21.56pp
2023-12-31	24.04%	CN¥390.59 Million ≈ $57.16 Million	CN¥1.62 Billion ≈ $237.72 Million	+3.05pp
2022-12-31	20.99%	CN¥389.51 Million ≈ $57.00 Million	CN¥1.86 Billion ≈ $271.51 Million	-2.04pp
2021-12-31	23.03%	CN¥579.13 Million ≈ $84.74 Million	CN¥2.51 Billion ≈ $367.93 Million	+16.41pp
2020-12-31	6.63%	CN¥180.00 Million ≈ $26.34 Million	CN¥2.72 Billion ≈ $397.47 Million	-11.97pp
2019-12-31	18.59%	CN¥355.78 Million ≈ $52.06 Million	CN¥1.91 Billion ≈ $280.00 Million	+2.88pp
2018-12-31	15.72%	CN¥325.00 Million ≈ $47.56 Million	CN¥2.07 Billion ≈ $302.60 Million	-14.56pp
2017-12-31	30.27%	CN¥500.00 Million ≈ $73.17 Million	CN¥1.65 Billion ≈ $241.69 Million	-6.93pp
2016-12-31	37.20%	CN¥500.00 Million ≈ $73.17 Million	CN¥1.34 Billion ≈ $196.67 Million	-7.46pp
2015-12-31	44.66%	CN¥600.00 Million ≈ $87.80 Million	CN¥1.34 Billion ≈ $196.60 Million	--

pp = percentage points

About Lionco Pharm Grp Co Ltd

SHG:603669 China Drug Manufacturers - Specialty & Generic

Market Cap

$472.82 Million

CN¥3.23 Billion CNY

Market Cap Rank

#12813 Global

#4009 in China

Share Price

CN¥4.48

Change (1 day)

-1.54%

52-Week Range

CN¥4.05 - CN¥6.97

All Time High

CN¥12.67